Evidence map›Paper›PMID 36258306›Full record

ArticleJournal of gastroenterology and hepatology2023

Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.

Paris Charilaou, Sonmoon Mohapatra, Sotirios Doukas, Maanit Kohli, Dhruvil Radadiya, Kalpit Devani, Arkady Broder, Olivier Elemento, Dana J Lukin, Robert Battat

Abstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paris CharilaouNew York Presbyterian Hospital/Weill-Cornell Medical College - Jill Roberts Center for Inflammatory Bowel Disease, Weill Cornell Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0002-5512-4225
Sonmoon MohapatraDivision of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA.
Sotirios DoukasDepartment of Medicine, Saint Peter's University Hospital/Rutgers-RWJ Medical School, New Brunswick, New Jersey, USA.
Maanit KohliDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Dhruvil RadadiyaDivision of Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0001-6061-7852
Kalpit DevaniDivision of Gastroenterology and Hepatology, Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, USA.
Arkady BroderDivision of Gastroenterology and Hepatology, Saint Peter's University Hospital/Rutgers-RWJ Medical School, New Brunswick, New Jersey, USA.
Olivier ElementoWeill Cornell Medical College - Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
Dana J LukinNew York Presbyterian Hospital/Weill-Cornell Medical College - Jill Roberts Center for Inflammatory Bowel Disease, Weill Cornell Medicine, New York, New York, USA.
Robert BattatDepartment of Gastroenterology and Hepatology, Centre Hospitalier de l' Universite de Montreal, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimData are lacking on predicting inpatient mortality (IM) in patients admitted for inflammatory bowel disease (IBD). IM is a critical outcome; however, difficulty in its prediction exists due to infrequent occurrence. We assessed IM predictors and developed a predictive model for IM using machine-learning (ML).

methodsUsing the National Inpatient Sample (NIS) database (2005-2017), we extracted adults admitted for IBD. After ML-guided predictor selection, we trained and internally validated multiple algorithms, targeting minimum sensitivity and positive likelihood ratio (+LR) ≥ 80% and ≥ 3, respectively. Diagnostic odds ratio (DOR) compared algorithm performance. The best performing algorithm was additionally trained and validated for an IBD-related surgery sub-cohort. External validation was done using NIS 2018.

resultsIn 398 426 adult IBD admissions, IM was 0.32% overall, and 0.87% among the surgical cohort (n = 40 784). Increasing age, ulcerative colitis, IBD-related surgery, pneumonia, chronic lung disease, acute kidney injury, malnutrition, frailty, heart failure, blood transfusion, sepsis/septic shock and thromboembolism were associated with increased IM. The QLattice algorithm, provided the highest performance model (+LR: 3.2, 95% CI 3.0-3.3; area-under-curve [AUC]:0.87, 85% sensitivity, 73% specificity), distinguishing IM patients by 15.6-fold when comparing high to low-risk patients. The surgical cohort model (+LR: 8.5, AUC: 0.94, 85% sensitivity, 90% specificity), distinguished IM patients by 49-fold. Both models performed excellently in external validation. An online calculator (https://clinicalc.ai/im-ibd/) was developed allowing bedside model predictions.

conclusionsAn online prediction-model calculator captured > 80% IM cases during IBD-related admissions, with high discriminatory effectiveness. This allows for risk stratification and provides a basis for assessing interventions to reduce mortality in high-risk patients.

Indexed as

Colitis, UlcerativeInflammatory Bowel DiseasesPneumoniaAdultHumansInpatientsMachine LearningRetrospective Studiesartificial intelligencecalculatorhospitalized patientsIBDmachine learningprediction model

Identifiers

PMID36258306
PMCPMC10099396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.